Who We Are
Our dedicated team of scientists, clinicians, collaborators and industry experts share a unified vision: to improve outcomes, advance therapies, and redefine the narrative for patients of hormone-driven cancers and rare diseases.
MANAGEMENT TEAM
Steven C. Quay
M.D., Ph.D.
Chairman of the Board and Chief Executive Officer
Mark Daniel
Chief Financial Officer
Delly Behen
Senior Vice President, Business Operations
Janet R. Rea, MSPH
Senior Vice President, Research & Development
BOARD of DIRECTORS
Steven C. Quay
M.D., Ph.D.
Chairman of the Board and Chief Executive Officer
Shu-Chih Chen, Ph.D.
Director
Tessa Cigler, M.D., M.P.H
Director
Jonathan F. Finn
Director
Stephen J. Galli, MD
Director
H. Lawrence Remmel, Esq.
Director
